drugset / Trial / NCT04359511

Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia

NCT04359511

Phase 3 Withdrawn University Hospital, Tours
RandomizedParallel-groupSingle-blindTreatment

Summary

To date, there is no efficient therapeutics to prevent or treat COVID-19 related pulmonary failure. Corticosteroids (CS) could be a helpful therapeutic. Retrospective reports suggested survival improvement in patients with acute respiratory distress syndrome (ARDS). CT scan for COVID19 hospitalized patients showed sometimes unusual aspects of pneumonia, suggestive of an organizing phase of diffuse alveolar damage (DAD). We hypothesize that, in the context of alveolar aggression induced by COVID-19, CT scan could help to individualize patients with a high probability of pulmonary organizing process who could benefit from CS treatment.

Timeline

Start
2020-07-03
Primary completion
2020-07-03
Completion
2020-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 3.5 mg/kg Intravenous
Subject Prednisone Other / unclassified 0.7 mg/kg Oral

Indications